Air Products and Chemicals, Inc.

LSE:0HBH Stock Report

Market Cap: US$73.8b

Air Products and Chemicals Valuation

Is 0HBH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0HBH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0HBH ($334.91) is trading below our estimate of fair value ($502.61)

Significantly Below Fair Value: 0HBH is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0HBH?

Key metric: As 0HBH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0HBH. This is calculated by dividing 0HBH's market cap by their current earnings.
What is 0HBH's PE Ratio?
PE Ratio19.2x
EarningsUS$3.84b
Market CapUS$73.79b

Price to Earnings Ratio vs Peers

How does 0HBH's PE Ratio compare to its peers?

The above table shows the PE ratio for 0HBH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24.3x
RIO Rio Tinto Group
9.5x0.7%UK£85.2b
ANTO Antofagasta
27.1x18.3%UK£16.5b
CRDA Croda International
30.6x15.1%UK£5.0b
AI L'Air Liquide
30.2x11.1%€91.6b
0HBH Air Products and Chemicals
19.2x1.6%US$73.8b

Price-To-Earnings vs Peers: 0HBH is good value based on its Price-To-Earnings Ratio (19.2x) compared to the peer average (24.3x).


Price to Earnings Ratio vs Industry

How does 0HBH's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0HBH 19.2xIndustry Avg. 17.1xNo. of Companies12PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0HBH is expensive based on its Price-To-Earnings Ratio (19.2x) compared to the European Chemicals industry average (17.1x).


Price to Earnings Ratio vs Fair Ratio

What is 0HBH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0HBH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19.2x
Fair PE Ratio19x

Price-To-Earnings vs Fair Ratio: 0HBH is expensive based on its Price-To-Earnings Ratio (19.2x) compared to the estimated Fair Price-To-Earnings Ratio (19x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0HBH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$335.53
US$342.23
+2.0%
7.6%US$380.00US$275.00n/a21
Nov ’25US$310.14
US$333.16
+7.4%
8.0%US$385.00US$275.00n/a21
Oct ’25US$293.15
US$302.28
+3.1%
9.3%US$355.00US$210.00n/a23
Sep ’25US$275.75
US$300.51
+9.0%
9.7%US$355.00US$210.00n/a23
Aug ’25US$285.62
US$284.90
-0.3%
11.1%US$355.00US$210.00n/a23
Jul ’25US$249.32
US$280.69
+12.6%
11.0%US$355.00US$210.00n/a23
Jun ’25US$262.79
US$269.60
+2.6%
11.1%US$355.00US$210.00n/a23
May ’25US$237.74
US$270.84
+13.9%
11.7%US$355.00US$210.00n/a23
Apr ’25US$242.79
US$266.23
+9.7%
11.9%US$355.00US$210.00n/a22
Mar ’25US$236.12
US$272.03
+15.2%
13.3%US$355.00US$210.00n/a23
Feb ’25US$259.29
US$309.51
+19.4%
9.0%US$355.00US$240.00n/a23
Jan ’25US$274.03
US$308.94
+12.7%
8.6%US$355.00US$240.00n/a23
Dec ’24US$272.31
US$309.38
+13.6%
8.4%US$355.00US$240.00n/a23
Nov ’24US$283.42
US$331.93
+17.1%
6.3%US$380.00US$300.00US$310.1423
Oct ’24US$282.79
US$329.36
+16.5%
6.4%US$380.00US$300.00US$293.1523
Sep ’24US$298.66
US$328.66
+10.0%
6.7%US$380.00US$300.00US$275.7522
Aug ’24US$303.03
US$328.00
+8.2%
6.6%US$385.00US$300.00US$285.6222
Jul ’24US$298.61
US$326.17
+9.2%
6.3%US$385.00US$300.00US$249.3224
Jun ’24US$274.05
US$328.38
+19.8%
6.8%US$385.00US$300.00US$262.7924
May ’24US$294.74
US$328.74
+11.5%
6.7%US$375.00US$300.00US$237.7423
Apr ’24US$284.04
US$329.91
+16.2%
7.2%US$385.00US$300.00US$242.7923
Mar ’24US$291.44
US$331.79
+13.8%
7.5%US$386.00US$295.00US$236.1224
Feb ’24US$317.35
US$330.79
+4.2%
8.6%US$394.00US$280.00US$259.2924
Jan ’24US$308.94
US$322.91
+4.5%
8.8%US$394.00US$280.00US$274.0322
Dec ’23US$311.94
US$307.73
-1.4%
8.1%US$390.00US$270.00US$272.3122
Nov ’23US$251.80
US$290.32
+15.3%
7.3%US$335.00US$251.00US$283.4222

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies